Cargando…

Comparing the Effectiveness of Intravenous Tissue Plasminogen Activator and Dual Antiplatelet Therapy in Patients With Minor Stroke: A Meta-Analysis

The aim of this study was to compare the outcomes between dual antiplatelet therapy (DAPT) versus intravenous tissue plasminogen activator (IV t-PA) in patients with minor stroke. This meta-analysis follows the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting gui...

Descripción completa

Detalles Bibliográficos
Autores principales:	Monday, Obinna, Rawat, Anurag, Isaak, Abraham K, Manzoor, Amima, Jaiswal, Goldi, Saeed, Leena, Kumari, Ajanta, Amin, Adil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624328/ https://www.ncbi.nlm.nih.gov/pubmed/37927654 http://dx.doi.org/10.7759/cureus.46436

Ejemplares similares

Dual Antiplatelet Therapy in Patients With Minor Stroke Receiving Intravenous Thrombolysis
por: Xu, Zhaohan, et al.
Publicado: (2022)

The Impact of Cerebral Microbleeds Presence on Outcome Following Minor Stroke Treated With Antiplatelet Therapy
por: Sakuta, Kenichi, et al.
Publicado: (2020)

Factors affecting physician decision-making regarding antiplatelet therapy in minor ischemic stroke
por: Liu, Tingting, et al.
Publicado: (2022)

Corrigendum: Factors affecting physician decision-making regarding antiplatelet therapy in minor ischemic stroke
por: Liu, Tingting, et al.
Publicado: (2022)

Different Doses of Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: A Network Meta-Analysis
por: Li, Bing-Hu, et al.
Publicado: (2022)

Intravenous Tissue Plasminogen Activator in Combination With Mechanical Thrombectomy: Clot Migration, Intracranial Bleeding, and the Impact of “Drip and Ship” on Effectiveness and Outcomes
por: Chang, Adam, et al.
Publicado: (2020)

Pre-treatment of Single and Double Antiplatelet and Anticoagulant With Intravenous Thrombolysis for Older Adults With Acute Ischemic Stroke: The TTT-AIS Experience
por: Lin, Sheng-Feng, et al.
Publicado: (2021)

Personalised antiplatelet therapy based on pharmacogenomics in acute ischaemic minor stroke and transient ischaemic attack: study protocol for a randomised controlled trial
por: Zhang, Xiao-Guang, et al.
Publicado: (2019)

Corrigendum: Pre-treatment of Single and Double Antiplatelet and Anticoagulant With Intravenous Thrombolysis for Older Adults With Acute Ischemic Stroke: The TTT-AIS Experience
por: Lin, Sheng-Feng, et al.
Publicado: (2021)

Mechanical Thrombectomy With and Without Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis Using Nested Knowledge
por: Adusumilli, Gautam, et al.
Publicado: (2021)

Editorial: Antiplatelet Agents in Stroke Prevention
por: Feher, Gergely, et al.
Publicado: (2021)

Intravenous thrombolysis versus antiplatelet therapy in minor stroke patients with large vessel occlusion
por: Duan, Chunmiao, et al.
Publicado: (2023)

Antiplatelet Resistance and Thromboembolic Complications in Neurointerventional Procedures
por: Oxley, Thomas J., et al.
Publicado: (2011)

Management of Pediatric Strokes With Alteplase (Tissue Plasminogen Activator)
por: Filatov, Asia, et al.
Publicado: (2021)

Transvenous Catheter-Based Thrombolysis With Continuous Tissue Plasminogen Activator Infusion for Refractory Thrombosis in a Patient With Behcet’s Disease
por: Arif, Saeed, et al.
Publicado: (2020)

Tissue plasminogen activator and patients with acute ischemic stroke: The litigation landscape
por: Ganti, Latha, et al.
Publicado: (2022)

Efficacy and Safety of Antiplatelet Agents for Adult Patients With Ischemic Moyamoya Disease
por: Ye, Fei, et al.
Publicado: (2021)

Why Me? To Be an Ultra-Responder to Antiplatelet Therapy: A Case Report
por: Rosafio, Francesca, et al.
Publicado: (2021)

Biomarkers for Antiplatelet Therapies in Acute Ischemic Stroke: A Clinical Review
por: Alhazzani, Adel, et al.
Publicado: (2021)

Clopidogrel Resistance in Patients With Stroke Recurrence Under Single or Dual Antiplatelet Treatment
por: Kang, Hyun Goo, et al.
Publicado: (2021)

Effect of antiplatelet therapy on minor dental procedures
por: Malik, Altaf Hussain, et al.
Publicado: (2020)

Benefits and risks of antiplatelet therapy for moyamoya disease: a systematic review and meta-analysis
por: Liu, Tingting, et al.
Publicado: (2023)

Single-Center Outcomes of WATCHMAN™ Implantation with Comparison to Oral Anticoagulant and Dual Antiplatelet Therapy
por: Demiraj, Francis, et al.
Publicado: (2023)

Predicting Chronic Subdural Hematoma Recurrence and Stroke Outcomes While Withholding Antiplatelet and Anticoagulant Agents
por: Zanaty, Mario, et al.
Publicado: (2020)

A Case of Failed Dual Antiplatelet Therapy With Oral Anticoagulant in the Prevention of Acute Ischemic Stroke
por: Amoda, Oluyemisi, et al.
Publicado: (2021)

Impact of Diabetes on Platelet Function in Acute Ischemic Stroke Patients Taking Dual Antiplatelet Therapy
por: Guo, Yinping, et al.
Publicado: (2021)

Case report: Usefulness of angioscopy in determining antiplatelet drug reduction after carotid artery stenting
por: Fukutome, Kenji, et al.
Publicado: (2023)

Minor Role of Plasminogen in Complement Activation on Cell Surfaces
por: Hyvärinen, Satu, et al.
Publicado: (2015)

Antiplatelet Therapy in the Secondary Prevention of Non-cardioembolic Ischemic Stroke and Transient Ischemic Attack: A Mini-Review
por: Vališ, Martin, et al.
Publicado: (2021)

Dual-Antiplatelet Therapy May Not Be Associated With an Increased Risk of In-hospital Bleeding in Patients With Moderate or Severe Ischemic Stroke
por: Khazaal, Ossama, et al.
Publicado: (2021)

The Impact of Preinjury Use of Antiplatelet Drugs on Outcomes of Traumatic Brain Injury: A Systematic Review and Meta-Analysis
por: Cheng, Li, et al.
Publicado: (2022)

Antiplatelet vs. Anticoagulation in Cervical Artery Dissection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Liu, Sihua, et al.
Publicado: (2021)

Combination of Rescue Stenting and Antiplatelet Infusion Improved Outcomes for Acute Intracranial Atherosclerosis-Related Large-Vessel Occlusion
por: Baek, Jang-Hyun, et al.
Publicado: (2021)

Treatment Challenges in Acute Minor Ischemic Stroke
por: Slawski, Diana, et al.
Publicado: (2021)

Editorial: Challenges in Acute Minor Ischemic Stroke
por: Heldner, Mirjam R., et al.
Publicado: (2022)

A Canine Model of Hemorrhagic Transformation Using Recombinant Tissue Plasminogen Activator Administration After Acute Ischemic Stroke
por: Jiang, Run-Hao, et al.
Publicado: (2019)

Tissue-Type Plasminogen Activator and Tenecteplase-Mediated Increase in Blood Brain Barrier Permeability Involves Cell Intrinsic Complement
por: Keragala, Charithani B., et al.
Publicado: (2020)

Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis
por: Niu, Peng-Peng, et al.
Publicado: (2016)

Effect of Dual Antiplatelet Therapy on Shunt Outcomes in Patients with Aneurysmal Subarachnoid Hemorrhage: A Matched Cohort Pilot Study
por: Paisan, Gabriella M, et al.
Publicado: (2018)

Ultra-Short-Term Dual Antiplatelet Therapy in Treating Unruptured Brain Aneurysm With the Pipeline Flex-Shield Embolization Device
por: Delora, Adam, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i485p57ikdiq7d5nh4kidk486m